- Home
- BKD vs VCEL Comparison
BKD vs VCEL Comparison
Compare BKD & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKD
- VCEL
- Stock Information
- Founded
- BKD 2005
- VCEL 1989
- Country
- BKD United States
- VCEL United States
- Employees
- BKD N/A
- VCEL N/A
- Industry
- BKD Hospital/Nursing Management
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BKD Health Care
- VCEL Health Care
- Exchange
- BKD Nasdaq
- VCEL Nasdaq
- Market Cap
- BKD 1.7B
- VCEL 1.6B
- IPO Year
- BKD 2005
- VCEL 1997
- Fundamental
- Price
- BKD $8.83
- VCEL $36.89
- Analyst Decision
- BKD Buy
- VCEL Strong Buy
- Analyst Count
- BKD 3
- VCEL 6
- Target Price
- BKD $8.33
- VCEL $58.60
- AVG Volume (30 Days)
- BKD 2.6M
- VCEL 568.2K
- Earning Date
- BKD 11-06-2025
- VCEL 11-06-2025
- Dividend Yield
- BKD N/A
- VCEL N/A
- EPS Growth
- BKD N/A
- VCEL 2045.40
- EPS
- BKD N/A
- VCEL 0.13
- Revenue
- BKD $3,051,698,000.00
- VCEL $249,119,000.00
- Revenue This Year
- BKD $8.53
- VCEL $18.35
- Revenue Next Year
- BKD N/A
- VCEL $22.26
- P/E Ratio
- BKD N/A
- VCEL $275.77
- Revenue Growth
- BKD 4.23
- VCEL 16.13
- 52 Week Low
- BKD $4.45
- VCEL $29.24
- 52 Week High
- BKD $9.09
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- BKD 61.23
- VCEL 62.01
- Support Level
- BKD $8.56
- VCEL $35.47
- Resistance Level
- BKD $8.85
- VCEL $36.95
- Average True Range (ATR)
- BKD 0.26
- VCEL 1.49
- MACD
- BKD -0.01
- VCEL 0.37
- Stochastic Oscillator
- BKD 70.18
- VCEL 97.86
About BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.